Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression

C Chauveau, S Rémy, PJ Royer, M Hill… - Blood, 2005 - ashpublications.org
C Chauveau, S Rémy, PJ Royer, M Hill, S Tanguy-Royer, FX Hubert, L Tesson, R Brion…
Blood, 2005ashpublications.org
Abstract Heme oxygenase-1 (HO-1) is an intracellular enzyme that degrades heme and
inhibits immune responses and inflammation in vivo. In most cell types, HO-1 is inducible by
inflammatory stimuli and oxidative stress. Here we demonstrate that human monocyte-
derived immature dendritic cells (iDCs) and several but not all freshly isolated rat splenic DC
subsets and rat bone marrow-derived iDCs, spontaneously express HO-1. HO-1 expression
drastically decreases during human and rat DC maturation induced in vitro. In human …
Abstract
Heme oxygenase-1 (HO-1) is an intracellular enzyme that degrades heme and inhibits immune responses and inflammation in vivo. In most cell types, HO-1 is inducible by inflammatory stimuli and oxidative stress. Here we demonstrate that human monocyte-derived immature dendritic cells (iDCs) and several but not all freshly isolated rat splenic DC subsets and rat bone marrow-derived iDCs, spontaneously express HO-1. HO-1 expression drastically decreases during human and rat DC maturation induced in vitro. In human tissues, iDCs also express HO-1, whereas mature DCs do not. Induction of HO-1 expression with cobalt protoporphyrin (CoPP) in human and rat DCs inhibits lipopolysaccharide (LPS)-induced phenotypic maturation and secretion of proinflammatory cytokines, resulting in the inhibition of alloreactive T-cell proliferation. CoPP-treated DCs, however, retain the ability to produce the anti-inflammatory cytokine interleukin 10 (IL-10). Reactive oxygen species induced by LPS in DCs were inhibited by induction of HO-1. In conclusion, we identify, for the first time, the capacity of HO-1 to block maturation of DCs and to inhibit proinflammatory and allogeneic immune responses while preserving IL-10 production. This novel immune function for HO-1 may be of interest for the inhibition of immune responses in autoimmune diseases, transplantation, and other conditions involving activation of the immune system. (Blood. 2005;106:1694-1702)
ashpublications.org